Patients and disease characteristics between L-Asp fully administered and L-Asp truncated
| n . | Total . | L-Asp fully administered . | L-Asp truncated . | P value . |
|---|---|---|---|---|
| 50 . | 34 . | 16 . | ||
| No. of L-Asp treatments | ||||
| Median | 6 | 6 | 6 | |
| Range | 1-6 | 6 | 1-6 | |
| Immunophenotype, n (%) | .137 | |||
| B cell | 41 (82.0) | 30 (88.2) | 11 (68.8) | |
| T cell | 8 (16.0) | 4 (11.8) | 4 (25.0) | |
| MPAL | 1 (2.0) | 0 (0.0) | 1 (6.2) | |
| WBC, n (%) | .200 | |||
| ≤30 | 33 (66.0) | 20 (58.8) | 13 (81.3) | |
| >30 | 17 (34.0) | 14 (41.2) | 3 (18.7) | |
| Sex, n (%) | .546 | |||
| Male | 23 (46.0) | 17 (50.0) | 6 (37.5) | |
| Female | 27 (54.0) | 17 (50.0) | 10 (62.5) | |
| Grouped age, n (%), y | .735 | |||
| 16-35 | 18 (36.0) | 11 (32.4) | 7 (43.8) | |
| 36-55 | 22 (44.0) | 16 (47.1) | 6 (37.5) | |
| 56-65 | 10 (20.0) | 7 (20.5) | 3 (28.7) | |
| Age, y | .257 | |||
| Median | 39 | 41.5 | 37.5 | |
| Range | 16-64 | 18-64 | 16-63 | |
| Cause of death, n (%) | .738 | |||
| N/A (alive) | 38 (76.0) | 26 (76.5) | 12 (75.0) | |
| Dead | ||||
| Not related | 1 (2.0) | 0 (0.0) | 1 (6.3) | |
| Disease related | 6 (12.0) | 5 (14.7) | 1 (6.3) | |
| Transplant related | 5 (10.0) | 3 (8.8) | 2 (12.5) |
| n . | Total . | L-Asp fully administered . | L-Asp truncated . | P value . |
|---|---|---|---|---|
| 50 . | 34 . | 16 . | ||
| No. of L-Asp treatments | ||||
| Median | 6 | 6 | 6 | |
| Range | 1-6 | 6 | 1-6 | |
| Immunophenotype, n (%) | .137 | |||
| B cell | 41 (82.0) | 30 (88.2) | 11 (68.8) | |
| T cell | 8 (16.0) | 4 (11.8) | 4 (25.0) | |
| MPAL | 1 (2.0) | 0 (0.0) | 1 (6.2) | |
| WBC, n (%) | .200 | |||
| ≤30 | 33 (66.0) | 20 (58.8) | 13 (81.3) | |
| >30 | 17 (34.0) | 14 (41.2) | 3 (18.7) | |
| Sex, n (%) | .546 | |||
| Male | 23 (46.0) | 17 (50.0) | 6 (37.5) | |
| Female | 27 (54.0) | 17 (50.0) | 10 (62.5) | |
| Grouped age, n (%), y | .735 | |||
| 16-35 | 18 (36.0) | 11 (32.4) | 7 (43.8) | |
| 36-55 | 22 (44.0) | 16 (47.1) | 6 (37.5) | |
| 56-65 | 10 (20.0) | 7 (20.5) | 3 (28.7) | |
| Age, y | .257 | |||
| Median | 39 | 41.5 | 37.5 | |
| Range | 16-64 | 18-64 | 16-63 | |
| Cause of death, n (%) | .738 | |||
| N/A (alive) | 38 (76.0) | 26 (76.5) | 12 (75.0) | |
| Dead | ||||
| Not related | 1 (2.0) | 0 (0.0) | 1 (6.3) | |
| Disease related | 6 (12.0) | 5 (14.7) | 1 (6.3) | |
| Transplant related | 5 (10.0) | 3 (8.8) | 2 (12.5) |
MPAL, mixed phenotype acute leukemia; N/A, not applicable.